- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01140165
Cheese and Human Health
Effects of Hard Cheese and Butter on Markers of Cardiovascular Disease -A Randomized Controlled Dietary Human Intervention
The aim of this study is to examine if a diet rich in cheese will have a beneficial effect on risk markers of cardiovascular disease compared to a diet rich in butter.
The primary parameters are total cholesterol as well as LDL-, HDL cholesterol and triacylglycerol (TAG). The secondary parameters are hsCRP, markers of insulin resistance, fasting insulin and glucose (HOMA). Furthermore bloodpressure is measured.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Frederiksberg, Denmark
- Department of Human Nutrition
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Sign written consent
- Age: 20-70
- BMI: 20-32
- Refrain from dietary supplements and blood donations prior to, and during the study
Exclusion Criteria:
- Known or suspected abuse of alcohol, drugs or medication
- Poor compliance
- Current or previously cardiovascular disease
- Diabetes Mellitus or other severe chronic disease, including severe allergies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: butter
Danish butter
|
the effect of cheese intake versus butter intake on blood lipids (primarily)
Other Names:
|
|
Experimental: cheese
|
the effect of cheese intake versus butter intake on blood lipids (primarily)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
HDL cholesterol
Time Frame: 6 weeks
|
6 weeks
|
|
Total cholesterol
Time Frame: 6 weeks
|
6 weeks
|
|
LDL cholesterol
Time Frame: 6 weeks
|
6 weeks
|
|
Triglyceride
Time Frame: 6 weeks
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Blood pressure
Time Frame: 6 weeks
|
6 weeks
|
|
Insulin
Time Frame: 6 weeks
|
6 weeks
|
|
Glucose
Time Frame: 6 weeks
|
6 weeks
|
|
fasting hsCRP
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A308
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.